Table 1.
General clinical features.
| All Patients (N = 1073) | Women (n = 445) | Men (n = 628) | |
|---|---|---|---|
| Demographics and outcomes | |||
| Women: n (%) | 445 (41) | 445 (100) | 0 (0) |
| Age: median (IQR) | 74 (62–82) | 73 (61–81) | 75 (64–82) |
| In-hospital deaths: n (%) | 119 (11) | 48 (11) | 71 (11) |
| Nosocomial infections: n (%) | 136 (13) | 56 (13) | 80 (13) |
| Time to discharge (days): median (IQR) | 12 (8–20) | 12 (8–21) | 12 (8–19) |
| Morbidity | |||
| ADL/IADL dependence: n (%) | 436 (41) | 181 (41) | 255 (41) |
| Cardiovascular disorders: n (%) | 745 (69) | 300 (67) | 445 (71) |
| Cardiac disorders: n (%) | 566 (53) | 216 (49) | 350 (56) |
| Hypertension: n (%) | 583 (54) | 242 (54) | 341 (54) |
| Pulmonary disorders: n (%) | 517 (48) | 205 (46) | 312 (50) |
| Renal disorders: n (%) | 362 (34) | 134 (30) | 228 (36) |
| Upper gastrointestinal tract disorders: n (%) | 103 (10) | 41 (9) | 62 (10) |
| Lower gastrointestinal tract disorders: n (%) | 105 (10) | 51 (11) | 54 (9) |
| Liver disorders: n (%) | 170 (16) | 62 (14) | 108 (17) |
| Metabolic disorders: n (%) | 425 (40) | 187 (42) | 238 (38) |
| Immune-mediated disorders: n (%) | 180 (17) | 110 (25) | 70 (11) |
| Neoplastic disorders: n (%) | 350 (33) | 132 (30) | 218 (35) |
| End-stage neoplastic disorders: n (%) | 76 (7) | 33 (7) | 43 (7) |
| Neurological disorders: n (%) | 439 (41) | 179 (40) | 260 (41) |
| Psychiatric disorders: n (%) | 100 (9) | 51 (11) | 49 (8) |
| Immunocompromised subjects: n (%) | 226 (21) | 106 (24) | 120 (19) |
| CIRS total score: median (IQR) | 9 (6–13) | 9 (5–12) | 9 (6–13) |
| CIRS severity score: median (IQR) | 0.7 (0.4–0.9) | 0.6 (0.4–0.9) | 0.7 (0.5–1.0) |
| CIRS comorbidity score: median (IQR) | 3.0 (2.0–5.0) | 3.0 (2.0–5.0) | 3.5 (2.0–5.0) |
| Intensity of care | |||
| Continuous vital signs monitoring *: n (%) | 1045 (97) | 432 (97) | 613 (98) |
| Any oxygen support: n (%) | 589 (55) | 222 (50) | 367 (58) |
| Nasal cannulas or Venturi’s mask: n (%) | 488 (45) | 183 (41) | 305 (49) |
| Non-invasive ventilation: n (%) | 109 (10) | 42 (9) | 67 (11) |
| Intravenous treatments: n (%) | 999 (93) | 399 (90) | 600 (96) |
| Vasoactive circulation support with one drug at least once: n (%) | 17 (2) | 7 (2) | 10 (2) |
| Vasoactive circulation support with more than one drug at least once: n (%) | 0 (0) | 0 (0) | 0 (0) |
| Dialysis at least once: n (%) | 14 (1) | 3 (1) | 11 (2) |
| At least one in-ward non-standard procedure: n (%) | 177 (16) | 75 (17) | 102 (16) |
| At least one exit from the ward for other procedures: n (%) | 760 (71) | 315 (71) | 445 (71) |
| Patients requiring surgery: n (%) | 27 (3) | 14 (3) | 13 (2) |
| NEMS average score: median (IQR) | 18 (16–19) | 18 (16–19) | 18 (16–19) |
* urinary output monitoring for the majority of patients.